124 related articles for article (PubMed ID: 38599783)
1. Correspondence on 'Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer' by Luzarraga Aznar et al.
Zhang J; Sun Y
Int J Gynecol Cancer; 2024 Jun; 34(6):967. PubMed ID: 38599783
[No Abstract] [Full Text] [Related]
2. Response to: Correspondence on 'Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer' by Zhang and Sun.
Bebia V; Luzarraga Aznar A; Cabrera S
Int J Gynecol Cancer; 2024 Jun; 34(6):968. PubMed ID: 38599781
[No Abstract] [Full Text] [Related]
3. Prognostic role of transcription factor
Onoprienko A; Hofstetter G; Muellauer L; Dorittke T; Polterauer S; Grimm C; Bartl T
Int J Gynecol Cancer; 2024 Jun; 34(6):840-846. PubMed ID: 38508586
[TBL] [Abstract][Full Text] [Related]
4. Endometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical Dilemmas.
Buhtoiarova TN; Brenner CA; Singh M
Am J Clin Pathol; 2016 Jan; 145(1):8-21. PubMed ID: 26712866
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer risk.
Forma E; Wójcik-Krowiranda K; Jóźwiak P; Szymczyk A; Bieńkiewicz A; Bryś M; Krześlak A
Pathol Oncol Res; 2014 Jul; 20(3):597-602. PubMed ID: 24346708
[TBL] [Abstract][Full Text] [Related]
6. Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis.
Yoshida E; Terao Y; Hayashi N; Mogushi K; Arakawa A; Tanaka Y; Ito Y; Ohmiya H; Hayashizaki Y; Takeda S; Itoh M; Kawaji H
Sci Rep; 2017 Oct; 7(1):14160. PubMed ID: 29074988
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer.
Zhao J; Liu T; Yu G; Wang J
Tumour Biol; 2015 Feb; 36(2):1299-306. PubMed ID: 25355598
[TBL] [Abstract][Full Text] [Related]
8. The KRAS, ATR and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrence.
Buchynska L; Gordiienko I; Glushchenko N; Iurchenko N
PLoS One; 2024; 19(4):e0302075. PubMed ID: 38669256
[TBL] [Abstract][Full Text] [Related]
9. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
10. Integration of Clinical and Molecular Features into Prediction Models for Outcomes in Endometrial Cancer.
Miller MD; Devor EJ
Clin Obstet Gynecol; 2020 Mar; 63(1):40-47. PubMed ID: 31725417
[TBL] [Abstract][Full Text] [Related]
11. Expression of DJ-1 in endometrial cancer: close correlation with clinicopathological features and apoptosis.
Shu K; Xiao Z; Long S; Yan J; Yu X; Zhu Q; Mei T
Int J Gynecol Cancer; 2013 Jul; 23(6):1029-35. PubMed ID: 23727824
[TBL] [Abstract][Full Text] [Related]
12. Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.
Ring KL; Connor EV; Atkins KA; Ricketts W; Kashlan B; Modesitt SC
Int J Gynecol Cancer; 2013 Jun; 23(5):853-60. PubMed ID: 23552806
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory Factors in Primary Endometrial Cell Cultures Isolated from Cancer and Noncancerous Human Tissue-Focus on RAGE and IDO1.
Tkaczuk-Włach J; Kędzierski W; Jonik I; Sadok I; Filip A; Kankofer M; Polkowski W; Ziółkowski P; Gamian A; Staniszewska M
Cells; 2021 Apr; 10(5):. PubMed ID: 33922995
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
Shang P; Meng F; Liu Y; Chen X
Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
[TBL] [Abstract][Full Text] [Related]
15. The expression pattern of 19 genes predicts the histology of endometrial carcinoma.
Sung CO; Sohn I
Sci Rep; 2014 Jun; 4():5174. PubMed ID: 24894155
[TBL] [Abstract][Full Text] [Related]
16. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
[TBL] [Abstract][Full Text] [Related]
17. Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer.
Asami Y; Kobayashi Kato M; Hiranuma K; Matsuda M; Shimada Y; Ishikawa M; Koyama T; Komatsu M; Hamamoto R; Nagashima M; Terao Y; Itakura A; Kohno T; Sekizawa A; Matsumoto K; Kato T; Shiraishi K; Yoshida H
Br J Cancer; 2023 Apr; 128(8):1582-1591. PubMed ID: 36797358
[TBL] [Abstract][Full Text] [Related]
18. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
Fadare O; Parkash V
Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
[TBL] [Abstract][Full Text] [Related]
19. [Microcystic, elongated and fragmented invasion pattern in endometrial carcinoma: the clinicopathology analysis].
Zhang XB; Zhao CL; Qi XL; Qin Y; Wang Y; Shen DH
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):811-815. PubMed ID: 30585018
[No Abstract] [Full Text] [Related]
20. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
Van Gool IC; Stelloo E; Nout RA; Nijman HW; Edmondson RJ; Church DN; MacKay HJ; Leary A; Powell ME; Mileshkin L; Creutzberg CL; Smit VT; Bosse T
Mod Pathol; 2016 Feb; 29(2):174-81. PubMed ID: 26743472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
